Similarly, IL-10 is known to promote Socs3 gene expression (163), and melanoma-associated DC have been found to exhibit SOCS3-mediated inhibition of the M2 pyruvate kinase (PKM2) that catalyzes conversion of phosphoenolpyruvate into pyruvate in the final step of glycolysis (164). This evidence concerns the gene IL10 and melanoma.